Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-389-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
There is only limited data available on the genetic toxicity of D-Glucopyranose, oligomeric, butyl glycoside. In order to fulfil the standard information requirements set out in Annex VII and VIII, 8.4, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006, read-across from structurally related substances is conducted.
A detailed justification for the grouping of chemicals and read-across is provided in the technical dossier (see IUCLID Sections 7.1 and 13).
In vitro
For genetic toxicity, data on D-Glucopyranose, oligomeric, butyl glycoside (Mouse lymphoma assay) and on substances which share a strong structural relationship with D-Glucopyranose, oligomeric, butyl glycoside exist. Based on the category approach, the results of three studies on genetic toxicity in vitro of the category members D-Glucopyranose, oligomers, hexyl glycosides, D-Glucopyranose, oligomers, decyl octyl glycosides and D-Glucopyranose, oligomeric, C10-16-alkyl glycosides were used (Microbiological Associates, 1991).
- Gene mutation in bacteria
A bacterial gene mutation assay (Ames test) was conducted with D-Glucopyranose, oligomers, hexyl glycosides in compliance with OECD guideline 471 and under GLP conditions (SafePharm, 1998). In two series of experiments, the test substance at concentrations ranging from 50 to 5000 µg/plate did not induce mutations in Ames test in the absence and presence of metabolic activation in the selected strains of Salmonella typhimurium (TA 98, TA 100, TA 1535 and TA 1537) and Escherichia coli (WP2 uvrA).
- Gene mutation in mammalian cells
The genotoxic potential of D-Glucopyranose, oligomeric, butyl glycoside was assessed using a gene mutation assay in cultured mammalian cells (mouse lymphoma L5178Y cells) according to OECD guideline 476 (WIL Research Europe B.V., 2012). Based on a preliminary toxicity study, concentrations ranging from 1 to 2360 µg/mL were used for the treatment of cells in two independent experiments. Incubation times of 24 hours and 3 hours were used in the absence and presence of S9-mix, respectively. No increase in mutant frequency was observed at any of the concentration tested in both experiments. Therefore, it was concluded that under the conditions used in the study, the test material was not mutagenic at the TK-locus of mouse lymphoma L5178Y cells in the absence and presence of metabolic activation. An analogous Mouse lymphoma assay conducted with the structurally related category member D-Glucopyranose, oligomers, decyl octyl glycosides (CAS 68515-73-1) demonstrated no genetic toxicity in mammalian cells, either, and, therefore, supports the toxicological comparability of the substances in the category.
- Chromosome aberrations
D-Glucopyranose, oligomeric, C10-16-alkyl glycosides was assayed in an in vitro mammalian chromosome aberration test conducted according to OECD guideline 473 and in compliance with GLP (Henkel, 1995). In this experiment, Chinese hamster lung fibroblasts (V79) were treated with the test substance at concentrations up to 160 µg/mL. Continuous treatment for 4 h was performed with and without S9-mix followed by culture periods of 7, 20 and 28 h, respectively. For chromosome analysis, concentrations ranging from 2 to 80 µg/mL were selected. The test substance did not induce chromosomal aberrations at any of the concentrations tested, both in the presence or absence of metabolic activation. Under the conditions of this assay, the test substance did not show clastogenic activity in vitro.
Justification for selection of genetic toxicity endpoint
Hazard assessment is conducted based on a Mouse lymphoma assay with the substance itself and by means of read-across based on a category approach with structurally related substances according to the criteria laid down in Annex XI, 1.5 of Regulation (EC) No 1907/2006. The substances of the Category are generated by the reaction of D-glucose with alcohols of varying chain length and share identical structural characteristics only differing by the alkyl chain length of the respective alcohol and varying degree of oligomerisation. Upon hydrolysis they are degraded into glucose and fatty alcohols again which can be further metabolised by common endogenous pathways like glycolysis and, in case of the alcohols, degraded in the endogenous pathway of beta-oxidation subsequently to their oxidation into fatty acids. No specific study was selected, since three different endpoints are addressed by genetic toxicity in vitro: mutagenicity in bacteria, chromosomal aberration in mammalian cells and mutagenicity in mammalian cells; genetic toxicity in vivo is no mandatory endpoint according to Regulation (EC) No 1907/2006. However, all available in vitro and in vivo genetic toxicity studies were negative. All available studies are adequate and reliable based on the identified similarities in structure and intrinsic properties between source and target substance and overall quality assessment (refer to the endpoint discussion for further details).
Short description of key information:
In vitro:
RA-C, OECD 471 (Ames): negative
OECD 476 (Mouse lymphoma assay): negative
RA-C, OECD 473 (Chromosome aberration): negative
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The available data on genetic toxicity of D-Glucopyranose, oligomeric, butyl glycoside and substances structurally related to D-Glucopyranose, oligomeric, butyl glycoside according to the criteria laid down in Regulation (EC) No 1907/2006, Annex XI, 1.5, do not meet the criteria for classification according to Regulation (EC) 1272/2008 or Directive 67/548/EEC; therefore, D-Glucopyranose, oligomeric, butyl glycoside is not considered to exert genetic toxicity, either, and the data are thus conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.